Filing Details
- Accession Number:
- 0001179110-12-004229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-05 16:12:39
- Reporting Period:
- 2012-03-01
- Filing Date:
- 2012-03-05
- Accepted Time:
- 2012-03-05 16:12:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Synta Pharmaceuticals Corp | SNTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1325718 | Keizo Koya | C/O Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421 | Sr. Vp, Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-03-01 | 6,844 | $4.70 | 12,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2011, and were made in part to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock granted on March 1, 2011.
- The shares were sold in multiple transactions at prices ranging from $4.63 to $4.83 per share. The price reported above is the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
